Entering text into the input field will update the search result below

Salix Pharmaceuticals misses by $0.02, misses on revenue

  • Salix Pharmaceuticals (NASDAQ:SLXP): Q3 EPS of $1.53 misses by $0.02.
  • Revenue of $354.72M (+48.9% Y/Y) misses by $37.64M.
  • Shares -32.95%.
  • Press Release

Recommended For You

Related Stocks

SymbolLast Price% Chg
SLXP--
Salix Pharmaceuticals, Ltd.